Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Survival After Introduction Of HAART In People With Known Duration Of HIV-1 Infection

The Cascade Collaboration
Published 2000 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
We compared survival from HIV-1 seroconversion before and during the periods of highly-active antiretroviral therapy (HAART). Survival expectations were substantially better for HIV-1-infected individuals in 1997-98 (HAART period) compared with those in 1986-96 (pre-HAART period). Estimated survival 10 years from seroconversion was also substantially better in the later period.



This paper is referenced by
10.1097/00002030-200216004-00009
The changing clinical epidemiology of AIDS in the highly active antiretroviral therapy era
C. Sabin (2002)
SAARC Journal of Tuberculosis, Lung Diseases and HIV/AIDS
V. S. Salhotra (2009)
10.1016/j.arth.2013.06.015
Mid-term outcomes in HIV-positive patients after primary total hip or knee arthroplasty.
C. Lin (2014)
10.7448/IAS.18.1.20217
Economic and epidemiological impact of early antiretroviral therapy initiation in India
Manoj V Maddali (2015)
10.1097/00002030-200302140-00009
Effectiveness of highly active antiretroviral therapy in Spanish cohorts of HIV seroconverters: differences by transmission category
S. Pérez-Hoyos (2003)
10.1046/j.1365-2516.2003.00804.x
Progression of HIV infection and mortality by hepatitis C infection in patients with haemophilia over 20 years
M. Quintana (2003)
ncreased syphilis trend among patients in an AIDS information and prevention enter
sabel Hurtadoa (2018)
10.1080/09541020512331325653
HIV testing and the role of individual- and structural-level barriers and facilitators
L. Bond (2005)
10.2105/AJPH.91.7.1019
The Serostatus Approach to Fighting the HIV Epidemic: prevention strategies for infected individuals.
R. Janssen (2001)
10.1097/00002030-200307250-00012
Dramatic improvement in survival among adult Brazilian AIDS patients
J. Marins (2003)
10.1051/MEDSCI/2008242S151
La santé mentale des femmes séropositives en France à l'ère des thérapies antirétrovirales : quelles différences avec les hommes ? Quels enjeux ?
Marie Préau (2008)
The Impact of Illicit Drug Use on Adherence to Antiretroviral Therapy among HIV-Infected US Women
Y. Zhang (2015)
10.1002/cncr.20354
Malignancy‐related causes of death in human immunodeficiency virus–infected patients in the era of highly active antiretroviral therapy
F. Bonnet (2004)
10.1186/cc3811
Impact of HIV/AIDS on care and outcomes of severe sepsis
J. Mrus (2005)
10.1097/00002030-200401001-00013
Older age and plasma viral load in HIV-1 infection
K. Goodkin (2004)
10.1097/01.aids.0000194799.43799.ea
Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?
A. Mocroft (2005)
10.1097/QAD.0b013e32833ef6c4
CD4 decline in seroconverter and seroprevalent individuals in the precombination of antiretroviral therapy era
S. Lodi (2010)
10.1086/383033
Increase in sexual risk behavior associated with immunologic response to highly active antiretroviral therapy among HIV-infected injection drug users.
W. Tun (2004)
10.1080/09540120500431584
Oral contraception and unprotected sex with occasional partners of women HIV-infected through injection drug use
M. P. Carrieri (2006)
10.1007/PL00002149
Präoperative Risikoabschätzung und perioperatives Management HIV-infizierter Patienten
K. Becker (2001)
10.3851/IMP1612
Prevalence and risk factors for abnormal liver stiffness in HIV-infected patients without viral hepatitis coinfection: role of didanosine.
N. Merchante (2010)
10.1097/EDE.0b013e3181ce9950
The Effect of HAART on HIV RNA Trajectory Among Treatment-naïve Men and Women: A Segmental Bernoulli/Lognormal Random Effects Model With Left Censoring
Haitao Chu (2010)
10.1007/BF02386756
Antiretroviral therapy and declining AIDS mortality in New York City
T. Wong (2006)
10.3111/13696990802579966
Principal components analysis of drug expenditure and utilisation trends for major therapeutic classes in US Medicaid programmes
J. Guo (2008)
10.5380/RMU.V4I4.50646
PREVALÊNCIA DE DOENÇA RENAL CRÔNICA EM PACIENTES HIV-POSITIVO ACOMPANHADOS NO HC-UFPR
Eduardo Henrique Bonotto (2017)
10.1093/AJE/154.7.675
Methods to assess population effectiveness of therapies in human immunodeficiency virus incident and prevalent cohorts.
P. Tarwater (2001)
10.1016/S1885-5857(06)70032-9
[Mortality and morbidity in HIV-infected patients undergoing coronary artery bypass surgery: a case control study].
M. J. Jiménez-Expósito (2006)
10.1155/2009/749575
Oxidative Imbalance in HIV-1 Infected Patients Treated with Antiretroviral Therapy
A. Mandas (2009)
10.2165/00007256-200434080-00001
The Benefits of Exercise Training for Quality of Life in HIV/AIDS in the Post-HAART Era
J. Ciccolo (2004)
10.1093/IJE/DYH307
Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS.
C. Lewden (2005)
10.1097/QAI.0b013e31826f993c
No Association of Abacavir Use With Myocardial Infarction: Findings of an FDA Meta-Analysis
X. Ding (2012)
Épidémiologie des atteintes coronaires au cours de l’infection par le VIH
Murielle Mary-Krause (2005)
See more
Semantic Scholar Logo Some data provided by SemanticScholar